Fundraising Fox

Neumarker

Founded 2022 · 20 employees on LinkedIn · 1 known investors

Find your way into Neumarker

91 people in our graph share verified history with the Neumarker team — schools, employers, funds. One of them is your warm intro.

John Torreyunlockedknows Qiang Li · together at Santa Clara University (overlapped)
×2knows the team · via UTStarcom
×5knows the team · via Florida International University
knows the team · via Santa Clara University
×3knows the team · via Xi'an Jiaotong University

Neumarker develops machine learning and biophysical tools to advance neuropsychiatric drug development and clinical care for CNS disorders. The company serves pharmaceutical and clinical organizations working on psychiatric and neurological treatments.

Founders & leadership

Neumarker was founded in 2022 by Ken Wang and Qiang Li.

KWKen Wang
Ken WanginFounder, Chairman, and Chief Executive OfficerExecutive Officer, Director at Telesair
QLQiang Li
Qiang LiinCo-founder and Chief Technology OfficerHe previously held a Vice President of Engineering role in software development, with expertise in embedded software, mobile applications, and Unix/Linux systems.

Investors · 1

Frequently asked questions

What does Neumarker do?
Neumarker develops machine learning and biophysical tools to advance neuropsychiatric drug development and clinical care for CNS disorders. The company serves pharmaceutical and clinical organizations working on psychiatric and neurological treatments.
Who founded Neumarker?
Neumarker was founded by Ken Wang, Qiang Li in 2022.
Who are Neumarker's investors?
Neumarker's investors include Foothill Ventures.